FLUORODOPA F18 Drug Patent Profile
✉ Email this page to a colleague
When do Fluorodopa F18 patents expire, and what generic alternatives are available?
Fluorodopa F18 is a drug marketed by Feinstein and is included in one NDA.
The generic ingredient in FLUORODOPA F18 is fluorodopa f-18. One supplier is listed for this compound. Additional details are available on the fluorodopa f-18 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUORODOPA F18?
- What are the global sales for FLUORODOPA F18?
- What is Average Wholesale Price for FLUORODOPA F18?
Summary for FLUORODOPA F18
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Clinical Trials: | 13 |
| Patent Applications: | 181 |
| DailyMed Link: | FLUORODOPA F18 at DailyMed |
Recent Clinical Trials for FLUORODOPA F18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | PHASE2 |
| Andrew Newberg | Phase 2 |
| Thomas Jefferson University | Phase 2 |
US Patents and Regulatory Information for FLUORODOPA F18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feinstein | FLUORODOPA F18 | fluorodopa f-18 | SOLUTION;INTRAVENOUS | 200655-001 | Oct 10, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
